Clinical Trial: Study of Stapokibart Injection in Adolescent Subjects With Seasonal Allergic Rhinitis (SAR)

U.S., June 2 -- ClinicalTrials.gov registry received information related to the study (NCT07617324) titled 'Study of Stapokibart Injection in Adolescent Subjects With Seasonal Allergic Rhinitis (SAR)' on May 21.

Brief Summary: This study is a multicenter, single-arm, open-label, phase II study to evaluate the safety, pharmacokinetics, and immunogenicity of Stapokibart injection in Adolescent Patients with SAR.

Study Start Date: June, 2026

Study Type: INTERVENTIONAL

Condition: Seasonal Allergic Rhinitis (SAR)

Intervention: BIOLOGICAL: Stapokibart injection

subcutaneous injection

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Chengdu Kangnuoxing Biopharma,Inc.

Disclaimer: Curated by HT Syndication....